Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database

Blood (2019) 134 (Supplement_1): 498.

https://doi.org/10.1182/blood-2019-124430

Published: 2019

Journal Articles

Preliminary Results from a Phase II Study of the Combination of Azacitidine and Pembrolizumab in Patients with Higher-Risk Myelodysplastic Syndrome

Kelly S. Chien, MD, Jorge E. Cortes, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MD, MSc, Naval G. Daver, MD, Nitin Jain, MD, Kiran Naqvi, MD, MPH, Elias J. Jabbour, MD, Kimberly B. Sheppard, RN, Sherry A. Pierce, BSN, BA, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD

Blood (2018) 132 (Supplement 1): 464.

https://doi.org/10.1182/blood-2018-99-115720

Published: 2018

Journal Articles

Report of Rare Urachal Carcinoma Presenting with Thrombocytopenia and Microangiopathic Hemolytic Anemia

Ari H. Elman, MD, Zeba Singh, MD, Heather D. Mannuel, MD MBA, Mya S. Thein, MD

Blood (2014) 124 (21): 5026.

https://doi.org/10.1182/blood.V124.21.5026.5026

Published: 2014

Journal Articles

Positive Maternal-Fetal Outcomes with Treatment of Lymphoma During Pregnancy: UT MD Anderson Cancer Center Prospective Experience

Michelle A. Fanale, MD, Chao-Ming Lai, APN, Sue A Rimes, RN, Mildred M Ramirez, MD, Fredrick B Hagemeister, MD, Nathan H Fowler, MD, Anas Younes, MD, Luis E Fayad, MD, Maria Alma Rodriguez, MD, Francesco Turturro, MD, Felipe Samaniego, MD, MPH, Jorge E Romaguera, MD, Victor A Levin, MD, Sandra B Horowitz, PharmD, Joseph E Woolery, PharmD, Andrea Milbourne, MD

Blood (2012) 120 (21): 3670.

https://doi.org/10.1182/blood.V120.21.3670.3670

Published: 2012

Journal Articles

Granulocyte Concentrates From a Single High-Yield Apheresis Can Be Split to Support Multiple Patients

Fleur M. Aung, MD, Virgil M Reddy, MBBS, Benjamin Lichtiger, MD, PhD

Blood (2012) 120 (21): 4373.

https://doi.org/10.1182/blood.V120.21.4373.4373

Published: 2012

Journal Articles

Phase I Study of the Combination of 5-Azacitidine Sequentially with High-Dose Lenalidomide in Higher-Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Guillermo Garcia-Manero, Naval G. Daver, MD, Gautam Borthakur, Marina Konopleva, M.D., Ph.D., Farhad Ravandi, MD, William G. Wierda, MD, PhD, Zeev Estrov, Stefan Faderl, MD, Tapan Kadia, Kristy Rey, MS, RN, Cora Cheung, RN, Hagop M. Kantarjian

Blood (2011) 118 (21): 2613.

https://doi.org/10.1182/blood.V118.21.2613.2613

Published: 2011

Journal Articles

Pregnancy Outcomes among Patients with Chronic Myeloid Leukemia Treated with Dasatinib

Jorge Cortes, MD, Susan O’Brien, Patricia Ault, Gautam Borthakur, Elias Jabbour, Brigid Bradley-Garelik, Krisztina Debreczeni, Daniel Yang, David Liu, Hagop Kantarjian

Blood (2008) 112 (11): 3230.

https://doi.org/10.1182/blood.V112.11.3230.3230

Published: 2008

Journal Articles

Gestational Age Above 12 Weeks Predicts Favorable Obstetric Outcome in Women with Antiphospholipid Syndrome (APS) Associated with First-Trimester Recurrent Pregnancy Loss (RPL) Treated with Enoxaparin and Low Dose Aspirin.

Luis S. Noble, MD, Juan Herrada, MD, William H. Kutteh, MD, PhD

Blood (2007) 110 (11): 4004.

https://doi.org/10.1182/blood.V110.11.4004.4004

Published: 2007

Journal Articles

False Positive Pregnancy Test Resulting from Passive Transfusion of beta-Human Chorionic Gonadotropin (bHCG) from Donor Red Blood Cells.

Suresh G. Shelat, MD, PhD, David F. Friedman, MD, Kim Smith-Whitley, MD, Geralyn Meny, MD

Blood (2006) 108 (11): 4152.

https://doi.org/10.1182/blood.V108.11.4152.4152

Published: 2006

Journal Articles

Time to First Progression, but Not Β2-Microglobulin, Predicts Outcome in Myeloma Patients Who Received Thalidomide as Salvage Therapy.

Antonio Palumbo, MD, Sara Bringhen, MD, Patrizia Falco, MD, Cecilia Rus, MD, Federica Cavallo, MD, Maria Teresa Ambrosini, MD, Ilaria Avonto, MD, Francesca Gay, MD, Gabriele Gallone, MD, Tommaso Caravita, MD, Benedetto Bruno, MD, Mario Boccadoro, MD

Blood (2006) 108 (11): 3562.

https://doi.org/10.1182/blood.V108.11.3562.3562

Published: 2006

NARROW

Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database

Preliminary Results from a Phase II Study of the Combination of Azacitidine and Pembrolizumab in Patients with Higher-Risk Myelodysplastic Syndrome

Report of Rare Urachal Carcinoma Presenting with Thrombocytopenia and Microangiopathic Hemolytic Anemia

Positive Maternal-Fetal Outcomes with Treatment of Lymphoma During Pregnancy: UT MD Anderson Cancer Center Prospective Experience

Granulocyte Concentrates From a Single High-Yield Apheresis Can Be Split to Support Multiple Patients

Phase I Study of the Combination of 5-Azacitidine Sequentially with High-Dose Lenalidomide in Higher-Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Pregnancy Outcomes among Patients with Chronic Myeloid Leukemia Treated with Dasatinib

Gestational Age Above 12 Weeks Predicts Favorable Obstetric Outcome in Women with Antiphospholipid Syndrome (APS) Associated with First-Trimester Recurrent Pregnancy Loss (RPL) Treated with Enoxaparin and Low Dose Aspirin.

Low Dose Rituximab in Adult Patients with Idiopathic Thrombocytopenic Purpura.

False Positive Pregnancy Test Resulting from Passive Transfusion of beta-Human Chorionic Gonadotropin (bHCG) from Donor Red Blood Cells.

Time to First Progression, but Not Β2-Microglobulin, Predicts Outcome in Myeloma Patients Who Received Thalidomide as Salvage Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only